about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersThe loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylationNo significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatinA universal assay for detection of oncogenic fusion transcripts by oligo microarray analysisTMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesionsGenome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomasExpression changes of the MAD mitotic checkpoint gene family in renal cell carcinomas characterized by numerical chromosome changesGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSCorrespondence: SEMA4A variation and risk of colorectal cancerRe: Role of the oxidative DNA damage repair gene OGG1 in colorectal tumorigenesisIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors.Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples.Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumorsEvaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersProstate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyCysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion geneTranscriptome instability as a molecular pan-cancer characteristic of carcinomasCernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesisAcute myeloid leukemia with inv(8)(p11q13).Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients.Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion.Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes.Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.Cytogenetic clues to breast carcinogenesis.Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
P50
Q21144874-D7C4E68A-29D3-4AE2-8A5F-42A51F50AA6CQ21245744-00BF029B-DBED-4A2D-A01E-D93A7E72F2BEQ24531843-60AD7B4C-5AE0-420C-B549-000DECF2989DQ24642548-DCA59826-5191-43E1-8BBC-F57CE6386CCEQ24678489-951A7C76-8492-4BE1-9A4E-CF78CDF27735Q24801499-1A5BEDF0-910C-4741-89CB-DA719E6F62FCQ28203701-736BD29B-8A7D-414F-9C94-06065F482F7DQ28291112-665BA582-6062-4B4D-B5DF-3E54A6E746B5Q28388497-40112ED5-E28E-4791-B2B7-801017A6CD22Q28584533-1D625AEB-F225-4297-8EE6-CAF3203E4530Q28602609-81944205-09FF-4E3D-A06F-14870386B5ADQ28606428-03145F9D-C8FA-4F0A-9E02-36913E1CD099Q29417155-D7345D92-BC83-4484-BB7A-5C782F14ADE4Q30252854-AE53C851-BC93-4E5E-A524-0B90B1F5F3C7Q30374367-CE6DD9ED-CF83-4061-B1B9-4CF91D085D13Q30988828-C90D2E3F-E257-4FBC-8C87-1D371045EFEBQ31043651-68ACA8C4-A455-4212-893D-16D5AA4D8F7FQ33291459-4FF152AC-0E47-4953-B516-88661094F837Q33393498-C8160505-343A-41B9-8E6C-7F6CDA73505BQ33575005-A25A7A26-F3A5-4D13-9D9E-ADC4AE157410Q33578217-0291E3BB-AB71-4DA9-9BF2-30FB159B6A9BQ33614244-D943AD29-BA19-4CC4-A98C-DC8B75C0A7C3Q33640983-0408E1AE-6A0F-485A-B438-51E286DA5ED7Q33652528-9C6138D7-4B42-4127-B21E-5CE4AF669CFFQ33709910-99FAD2F3-3539-4632-89BE-8EBD80D02B4AQ33729779-1C87B1C8-31DB-4D94-9A65-ECC2A8C9D30FQ33927384-DAB39D68-EB49-49AC-8304-AD26D1FB553AQ33981506-AC5780F8-42DF-4F0B-9193-E8C0E881A2BBQ34041693-19ECB54A-06C7-4B54-956E-B4D84327C45DQ34152519-0497611C-04D2-4121-A397-72E6F4B7A247Q34244496-46A60F9E-8929-4035-90A2-05F8732326ADQ34286369-AA8A0737-7D5B-4250-ACBD-3F5B1A8585BDQ34301309-CBE67C7F-4F1D-48BD-B286-BD11AA6F46C5Q34323234-E1C47755-18FE-4AE2-AC46-73884011602BQ34353717-B01CD7C5-9ABB-460A-9137-501DE2C42AA7Q34410160-92A30E6D-5ADC-4EF9-A7FF-79A873179478Q34419515-88BAE48C-C532-4163-850C-305CE21749B9Q34464929-C3B3F090-133F-4C76-A494-64FEEF055A0FQ34469005-AEFDC519-7045-4070-9C38-8B5B3B08F825Q34556958-1BDF01A6-66E9-4386-BAA3-56CEA5106074
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Manuel R. Teixeira
@ast
Manuel R. Teixeira
@en
Manuel R. Teixeira
@es
Manuel R. Teixeira
@nl
Manuel R. Teixeira
@sl
type
label
Manuel R. Teixeira
@ast
Manuel R. Teixeira
@en
Manuel R. Teixeira
@es
Manuel R. Teixeira
@nl
Manuel R. Teixeira
@sl
altLabel
Manuel Teixeira
@en
Teixeira MR
@en
prefLabel
Manuel R. Teixeira
@ast
Manuel R. Teixeira
@en
Manuel R. Teixeira
@es
Manuel R. Teixeira
@nl
Manuel R. Teixeira
@sl
P214
P1053
E-4885-2011
P106
P1153
7202390422
P21
P214
P31
P3829
P496
0000-0002-4896-5982
P735
P7859
viaf-98957008